Rosemary E. Millard

603 total citations
24 papers, 483 citations indexed

About

Rosemary E. Millard is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Rosemary E. Millard has authored 24 papers receiving a total of 483 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 9 papers in Hematology and 9 papers in Immunology. Recurrent topics in Rosemary E. Millard's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Rosemary E. Millard is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Rosemary E. Millard collaborates with scholars based in United Kingdom and France. Rosemary E. Millard's co-authors include H. E. M. Kay, Sylvia D. Lawler, N. M. Blackett, R Gérard-Marchant, E.H. Cooper, Iris Hamlin, Michael Peckham, L. Hudson, Alan P. Johnstone and Catherine Cameron and has published in prestigious journals such as Nature, Journal of Cellular Physiology and British Journal of Haematology.

In The Last Decade

Rosemary E. Millard

23 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosemary E. Millard United Kingdom 14 218 207 101 87 76 24 483
Rita Michalevicz Israel 14 134 0.6× 177 0.9× 97 1.0× 163 1.9× 75 1.0× 31 422
RD Brunning United States 14 173 0.8× 233 1.1× 60 0.6× 185 2.1× 117 1.5× 24 536
WC Moloney United States 9 141 0.6× 202 1.0× 72 0.7× 137 1.6× 34 0.4× 14 401
D Manor Israel 7 248 1.1× 369 1.8× 170 1.7× 161 1.9× 70 0.9× 18 688
A. Lakhani United Kingdom 11 171 0.8× 170 0.8× 53 0.5× 81 0.9× 85 1.1× 16 356
Paul I. Liu United States 7 75 0.3× 245 1.2× 95 0.9× 30 0.3× 75 1.0× 12 421
H. J. Adriaansen Netherlands 12 142 0.7× 256 1.2× 172 1.7× 188 2.2× 120 1.6× 20 568
G Sébahoun France 14 207 0.9× 183 0.9× 73 0.7× 240 2.8× 151 2.0× 61 585
Elfenbein Gj United States 16 93 0.4× 369 1.8× 41 0.4× 182 2.1× 122 1.6× 36 550
Françoise Accard France 7 108 0.5× 279 1.3× 160 1.6× 167 1.9× 124 1.6× 11 495

Countries citing papers authored by Rosemary E. Millard

Since Specialization
Citations

This map shows the geographic impact of Rosemary E. Millard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary E. Millard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary E. Millard more than expected).

Fields of papers citing papers by Rosemary E. Millard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary E. Millard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary E. Millard. The network helps show where Rosemary E. Millard may publish in the future.

Co-authorship network of co-authors of Rosemary E. Millard

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary E. Millard. A scholar is included among the top collaborators of Rosemary E. Millard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary E. Millard. Rosemary E. Millard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Millard, Rosemary E., et al.. (1988). Functional studies of cell‐mediated immunity in haemophilia and other bleeding disorders. British Journal of Haematology. 69(3). 367–370. 21 indexed citations
2.
Millard, Rosemary E., et al.. (1987). Serial studies of T-lymphocyte subpopulations in HIV seropositive haemophiliacs. Clinical & Laboratory Haematology. 9(2). 109–114. 1 indexed citations
3.
Murphy, Joe, Vera Malkovska, L. Hudson, & Rosemary E. Millard. (1987). Expression of functional interleukin 2 receptors on chronic lymphocytic leukaemia B lymphocytes is modulated by recombinant interleukin 2.. PubMed. 70(1). 182–91. 5 indexed citations
4.
Johnstone, Alan P. & Rosemary E. Millard. (1985). Quantitation of Immunoglobulin Isotypes in Chronic Lymphocytic Leukaemic Cells Compared with Normal Adult and Neonatal Lymphocytes. International Archives of Allergy and Immunology. 76(4). 313–317. 3 indexed citations
5.
Johnstone, Alan P., Jens C. Jensenius, Rosemary E. Millard, & L. Hudson. (1982). Mitogen-stimulated immunoglobulin production by chronic lymphocytic leukaemic lymphocytes.. PubMed. 47(3). 697–705. 23 indexed citations
6.
Johnstone, Alan P., Rosemary E. Millard, & L. Hudson. (1982). The roles of leukaemic and residual normal cells in the proliferative response of chronic lymphocytic leukaemic lymphocytes to mitogens.. PubMed. 47(3). 689–96. 3 indexed citations
7.
Johnstone, Alan P., Susan E. Height, & Rosemary E. Millard. (1982). Disturbances in T-cell subpopulations in B-cell chronic lymphocytic leukaemia. Bioscience Reports. 2(8). 535–542.
8.
Millard, Rosemary E. & N. M. Blackett. (1981). Radiosensitivity and Recovery of Two Murine Haemopoietic Progenitor Cell Populations following Gamma Rays and Neutrons. Acta Haematologica. 66(4). 226–232. 7 indexed citations
9.
Millard, Rosemary E., et al.. (1981). Studies of T, B, and ‘Null’ Blood Lymphocytes in Normal Persons of Different Age Groups. Gerontology. 27(1-2). 79–84. 9 indexed citations
10.
Millard, Rosemary E. & D Banerjee. (1979). Changes in T and B blood lymphocytes after splenectomy.. Journal of Clinical Pathology. 32(10). 1045–1049. 15 indexed citations
11.
Blackett, N. M. & Rosemary E. Millard. (1976). Different recovery patterns of mouse haemopoietic stem cells in response to cytotoxic agents. Journal of Cellular Physiology. 89(3). 473–480. 6 indexed citations
12.
Millard, Rosemary E., et al.. (1975). THE EFFECT OF CYTOSINE ARABINOSIDE IN VITRO ON AGAR COLONY FORMING CELLS AND SPLEEN COLONY FORMING CELLS OF C57BL MOUSE BONE MARROW. Cell Proliferation. 8(1). 33–40. 14 indexed citations
13.
Blackett, N. M., et al.. (1974). THYMIDINE SUICIDE IN VIVO AND IN VITRO OF SPLEEN COLONY FORMING AND AGAR COLONY FORMING CELLS OF MOUSE BONE MARROW. Cell Proliferation. 7(4). 309–318. 18 indexed citations
14.
15.
Callender, Sheila T., H. E. M. Kay, S. D. Lawler, et al.. (1971). Two Populations of Rh Groups together with Chromosomally Abnormal Cell Lines in the Bone Marrow. BMJ. 1(5741). 131–133. 19 indexed citations
16.
Millard, Rosemary E., et al.. (1968). Further Observations on Patients with a Chromosomal Abnormality Associated with Polycythaemia Vera. British Journal of Haematology. 14(4). 363–374. 30 indexed citations
17.
Millard, Rosemary E.. (1968). Chromosome abnormalities in the malignant lymphomas. European Journal of Cancer (1965). 4(1). 97–105. 21 indexed citations
18.
Cooper, E.H., Michael Peckham, Rosemary E. Millard, Iris Hamlin, & R Gérard-Marchant. (1968). Cell proliferation in human malignant lymphomas. European Journal of Cancer (1965). 4(3). 287–296. 49 indexed citations
19.
Kay, H. E. M., Sylvia D. Lawler, & Rosemary E. Millard. (1966). The Chromosomes in Polycythaemia Vera. British Journal of Haematology. 12(5). 507–527. 78 indexed citations
20.
Millard, Rosemary E.. (1965). Effect of previous irradiation on the transformation of blood lymphocytes. Journal of Clinical Pathology. 18(6). 783–785. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026